Get informed when a big investor buys or sells
+ FollowOvervalued by 48.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.28 Billion |
|---|---|
| Enterprise Value | $1.39 Billion |
| Earnings per Share | $0.61 |
| Beta | 1.34 |
| Outstanding Shares | 24,097,277 |
| P/E Ratio | 24.73 |
|---|---|
| PEG | -56.52 |
| Price to Sales | 0.56 |
| Price to Book Ratio | 2.38 |
| Enterprise Value to Revenue | 0.64 |
| Enterprise Value to EBIT | 33.01 |
| Enterprise Value to Net Income | 124 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.38 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Pharmaceutical Supply, Patient-Specific Therapies, and Services. The Pharmaceutical Supply segment focuse...